Skip to content

INVESTORS

Three lines. The rest is a conversation.

Not a deck — a teaser. The full story lives across this site; here is why it's worth a call.

  1. 01The category

    A defensible, category-creating product: an AI technician with write-access to PrimeRxthat no dashboard has. Every funded competitor watches claims through glass and recommends. SSVP has its hands on the keyboard and a licensed pharmacist’s signature on every move.

  2. 02The moat

    Recurring, cash-protection revenue — money the pharmacy was about to lose — stacked on a payer-rules data flywheel. Every audit handled makes the next defense stronger, an asset human incumbents took decades to build, now accruing at software speed and impossible to backfill.

  3. 03The ask

    Build capital for the 15-month build, weighted toward payer-rules knowledge engineering; pilot partners who want the overlay in their stores first; and channel introductions into independent pharmacy. No numbers here beyond what’s already public on this site.

If that’s a thesis you want to underwrite, the next step is a direct email — no gatekeeper.

deep@deepshah.tech